Management of Grade 3a Follicular Lymphoma Following Relapse After Initial Treatment
Management of Grade 3a Follicular Lymphoma Following Relapse After Initial Treatment is organized by Projects In Knowledge Inc. (PIK).
Release Date: Mar 30, 2023
Termination Date: Mar 29, 2024
Activity Goal
The goal of this program is to provide data from medical meetings, expert analysis insights on current and emerging management strategies, and interactive case studies based on the most up-to-date evidence-based medicine and clinical trial results in follicular lymphoma.
Learning Objective(s):
Evaluate the efficacy and safety of first-line treatments for grade 3a follicular lymphoma (FL) based on results of the most recent phase I, II, and III clinical trials.
Review the current treatment landscape for relapsed or refractory grade 3a FL with an evaluation of best-suited treatments for individual patients.
Additional details will be posted as soon as information is available.